Crossref
Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study
Mathews Journal of Pharmaceutical Science · 2023
DOI: 10.30654/mjps.10021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mathews Journal of Pharmaceutical Science, 2023. Verfasst von Allen B Richon und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Richon, A. B., & Richon, M. A. (2023). Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study. Mathews Journal of Pharmaceutical Science. https://doi.org/10.30654/mjps.10021
Vancouver
Richon AB, Richon MA. Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study. Mathews Journal of Pharmaceutical Science. 2023. doi:10.30654/mjps.10021
BibTeX
@article{Richon2023,
author = {Richon, Allen B and Richon, Merry Ambos},
title = {Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study},
journal = {Mathews Journal of Pharmaceutical Science},
year = {2023},
doi = {10.30654/mjps.10021}
}
EUVIMED